Reactive Oxygen Species and Endothelial Migration
活性氧和内皮迁移
基本信息
- 批准号:7579146
- 负责人:
- 金额:$ 37.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-03-15 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:ActinsAdenovirusesAdherens JunctionAdhesionsAngiogenic FactorBindingBinding ProteinsBinding SitesBiological AssayBlood capillariesBlood flowCell Adhesion MoleculesCell-Cell AdhesionCellsComplementary DNAComplexConfocal MicroscopyCouplingDataDevelopmentE-CadherinEndothelial CellsEventGoalsGrowthHindlimbHydrogen PeroxideIn VitroIschemiaLaboratoriesLinkMediatingModelingMolecularMonomeric GTP-Binding ProteinsMorphogenesisMusOxidasesPeptidesProductionReactive Oxygen SpeciesRecoveryRecruitment ActivityRegulationResearch PersonnelRoleScaffolding ProteinSignal PathwaySignal TransductionSignaling MoleculeSmall Interfering RNASourceSpecificityStressTyrosine PhosphorylationVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth FactorsWild Type MouseWorkWound Healingangiogenesisbasecadherin 5capillarycell motilityin vivomigrationmutantnovelnovel therapeuticsoverexpressionpostnatalprogramsreceptorresponseresponse to injuryscaffoldwoundyeast two hybrid system
项目摘要
Endothelial cell (EC) migration is a key event for endothelial wound repair and angiogenesis. VEGF is a
potent stimulator for EC migration primarily through the VEGF type2 receptor (VEGFR2). In quiescent ECs,
one of the initial responses to stimulate endothelial migration by VEGF is the loosening of stable cell-cell
contacts which is regulated by tyrosine phosphorylation of VE-cadherin. We showed that VEGF stimulates
Rac1-dependent gp91phox-based NAD(P)H oxidase and that reactive oxygen species (ROS) are involved in
VEGFR2-mediated signaling linked to EC migration. Underlying molecular mechanisms are poorly
understood. We recently identified IQGAP1 as a novel VEGFR2 binding protein. It functions as a scaffold
protein that controls cell motility and morphogenesis by interacting with cytoskeletal and cell-cell adhesion
proteins including active Rac1 and E-cadherin. We also found that: 1) IQGAP1 expression is increased in
the newly-formed capillary ECs in a mouse hindlimb ischemia model of angiogenesis; 2) Overexpression of
IQGAP1 increases basal Rac1 activity, ROS production and cell migration in ECs; 3) VEGF promotes
recruitment of activated VEGFR2 and Rac1 to the IQGAP1-VE-cadherin complex at adherens junctions,
which may promote ROS-dependent loss of cell-cell contacts and subsequent EC migration; 4) Wound
assays reveal that IQGAP1 colocalizes with active VEGFR2 and gp91phox at the leading edge inactively
migrating ECs. We thus hypothesize that IQGAP1 functions as a VEGFR2 binding scaffold protein to link
ROS-dependent signaling with VEGF-mediated endothelial migration. Aim1 will examine whether IQGAP1
functionally interacts with VEGFR2 and Rac1 to couple VEGFR2 to ROS-dependent signaling linked to EC
migration. Aim2 will examine whether IQGAP1 functions as a scaffold to recruit activated VEGFR2 and Rac1
to adherens junctions through binding to VE-cadherin, thereby facilitating ROS-dependent loss of cell-cell
contacts, which initiates EC migration. Aim3 will examine the scaffolding role of IQGAP1 in targeting
VEGFR2 and NAD(P)H oxidase to the leading edge during directed cell migration. Aim4 will assess the
functional significance of IQGAP1 in vivo using mouse hindlimb ishcemia model. The long-term goal is to
understand the molecular mechanisms by which ROS regulate EC migration in the context of angiogenesis
and endothelial wound repair, which should facilitate the development of new therapeutic strategies.
内皮细胞(EC)迁移是内皮损伤修复和血管生成的关键事件。血管内皮生长因子是一个
主要通过血管内皮生长因子2型受体(VEGFR2)促进内皮细胞迁移。在静止的ECS中,
血管内皮生长因子刺激内皮细胞迁移的最初反应之一是稳定的细胞-细胞松动
VE-钙粘蛋白酪氨酸磷酸化调节的接触。我们发现,血管内皮生长因子可以刺激
基于rac1依赖gp91Phox的NAD(P)H氧化酶和活性氧自由基(ROS)参与
VEGFR2介导的与EC迁移相关的信号转导。潜在的分子机制很差
明白了。我们最近发现IQGAP1是一个新的VEGFR2结合蛋白。它起着脚手架的作用
通过与细胞骨架和细胞间黏附相互作用来控制细胞运动和形态发生的蛋白质
蛋白质包括活性的rac1和E-钙粘附素。我们还发现:1)IQGAP1的表达在
新生毛细血管内皮细胞在小鼠后肢缺血血管生成模型中的表达
IQGAP1促进内皮细胞基本的rac1活性、ROS的产生和细胞迁移;3)VEGF促进
在黏附连接将激活的VEGFR2和rac1募集到IQGAP1-VE-钙粘素复合体,
这可能促进依赖ROS的细胞-细胞接触的丧失和随后的EC迁移;4)创伤
分析表明,IQGAP1与活性的VEGFR2和gp91Phox在前沿被动地共定位
正在迁移EC。因此,我们假设IQGAP1作为VEGFR2结合的支架蛋白来连接
ROS依赖的信号与血管内皮生长因子介导的内皮迁移。AIM1将检查IQGAP1是否
在功能上与VEGFR2和rac1相互作用,将VEGFR2与ROS依赖的信号连接到EC
迁移。AIM2将检查IQGAP1是否作为支架招募激活的VEGFR2和rac1
TO通过与VE-钙粘附素结合来黏附连接,从而促进细胞-细胞内ROS依赖性的丢失
联系人,这会启动EC迁移。Aim3将研究IQGAP1在靶向中的支架作用
在细胞定向迁移过程中,VEGFR2和NAD(P)H氧化酶被转移到前沿。AIM4将评估
IQGAP1在小鼠后肢缺血模型体内的功能意义。长期目标是
了解ROS在血管生成背景下调节EC迁移的分子机制
和内皮伤口修复,这应该有助于开发新的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Masuko Ushio-Fukai其他文献
Masuko Ushio-Fukai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Masuko Ushio-Fukai', 18)}}的其他基金
Mitochondria Dynamics Protein Drp1 in ROS Signaling, Endothelial Metabolism and Angiogenesis
线粒体动力学蛋白 Drp1 在 ROS 信号传导、内皮代谢和血管生成中的作用
- 批准号:
10475228 - 财政年份:2021
- 资助金额:
$ 37.63万 - 项目类别:
Mitochondria Dynamics Protein Drp1 in ROS Signaling, Endothelial Metabolism and Angiogenesis
线粒体动力学蛋白 Drp1 在 ROS 信号传导、内皮代谢和血管生成中的作用
- 批准号:
10666540 - 财政年份:2021
- 资助金额:
$ 37.63万 - 项目类别:
Mitochondria Dynamics Protein Drp1 in ROS Signaling, Endothelial Metabolism and Angiogenesis
线粒体动力学蛋白 Drp1 在 ROS 信号传导、内皮代谢和血管生成中的作用
- 批准号:
10317794 - 财政年份:2021
- 资助金额:
$ 37.63万 - 项目类别:
Protein Disulfide Isomerase as Novel Redox Sensor in VEGF Signaling
蛋白质二硫键异构酶作为 VEGF 信号转导中的新型氧化还原传感器
- 批准号:
9479934 - 财政年份:2016
- 资助金额:
$ 37.63万 - 项目类别:
Role of Cysteine Sulfenic Acid Formation in Compartmentalization of VEGF Signalin
半胱氨酸磺酸形成在 VEGF 信号蛋白区室化中的作用
- 批准号:
8445715 - 财政年份:2013
- 资助金额:
$ 37.63万 - 项目类别:
Role of Cysteine Sulfenic Acid Formation in Compartmentalization of VEGF Signalin
半胱氨酸磺酸形成在 VEGF 信号蛋白区室化中的作用
- 批准号:
8620710 - 财政年份:2013
- 资助金额:
$ 37.63万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 37.63万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 37.63万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 37.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 37.63万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 37.63万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 37.63万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 37.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 37.63万 - 项目类别:
Discovery Grants Program - Individual
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 37.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 37.63万 - 项目类别:
Studentship














{{item.name}}会员




